secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantern Pharma Inc. (LTRN)
CIK:        0001763950
Form:       8-K
Filed at:   2022-04-25T23:59:59+00:00
Accession:  0001213900-22-021397
Event type: other
Sentiment:  neutral
Materiality: 0.00
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lantern Pharma provides disclosure channels reminder; no material news
----------------------------------------------------------------------

- Filing details company's website, press releases, SEC filings, newsletters, and social media as information channels.
- No financial results, clinical updates, or material events reported.
- Company reiterates emerging growth company status and extended transition period election.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1763950/000121390022021397/0001213900-22-021397-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1763950/000121390022021397/ea158814-8k_lantern.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-021397

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer